|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/55 | (2013.01) |
| A61K 38/55 | (2006.01) | ||
| A61K 35/16 | (2015.01) | ||
| A61K 35/16 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/00 | (2013.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 38/57 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3494988 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18205998.0 |
| Date of filing the European patent application | 2014-11-21 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361907550 P | 2013-11-22 | US | |
| 201462029086 P | 2014-07-25 | US |
| (72) |
BROOM, Colin , US
UKNIS, Marc, E. , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | TREATMENT OF ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR |
| TREATMENT OF ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR |